anti-LAG-3 peptide (University of Missouri)

N/A

Report date: 2025/06/11 10:27:37

Base Information

Drug Nameanti-LAG-3 peptide (University of Missouri)
Drug Alias NameLAG-3 checkpoint inhibitor (University of Missouri)CMA-16
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionImmunostimulantsT lymphocytes stimulantsLymphocyte activation gene 3 protein inhibitors
TargetsLymphocyte activation gene 3 protein
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Missouri
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Missouri
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A